Cure Today: Poor Liver Function Can Cause Side Effects, Drug Discontinuation in HCC Patients with unresectable hepatocellular carcinoma and poor liver function were more likely to experience serious side effects leading to regorafenib treatment discontinuation, researchers have found ... Medscape: Women With Cardiometabolic Risks More Prone to Liver Fibrosis Than Men Women had a lower overall prevalence of clinically significant liver fibrosis than men. However, having two or more cardiometabolic risk factors, a large waist circumference, or glucose intolerance ...
MedPage Today: Serious Outcomes of Steatotic Liver Disease Hit Men and Women Differently Serious outcomes associated with metabolic dysfunction-associated steatotic liver disease (MASLD) -- including liver cancer, cirrhosis, heart disease, and more -- affect men and women differently, a ... MedPage Today: Higher Odds of Liver Fibrosis in Women With Cardiometabolic Risks A cross-sectional study found women with multiple cardiometabolic risk factors may face disproportionately higher odds of clinically significant liver fibrosis than men with similar profiles. The ...
